The Supreme Court of India rejected the special leave petition filed by Bayer Corporation, a leading pharmaceutical company. This petition was filed against the Delhi High Court’s decision in February 2010 regarding the dismissal of patent linkage in India. Bayer’s Corporation had filed a written petition before the Delhi High court against Union of India and Cipla Ltd. The petition was made seeking an order that the Drug Controller General of India should consider the patent status of its drug, which treats renal cancer before granting a marketing approval to any generic versions of the drug and refuse marketing approval to any generic version.
Image from www.bayer.com
0 comments:
Post a Comment